Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Brenner

Showing results (671-680 of 989) with videos related to

Pageof 99
Sort By:
Clinical Lung Cancer|February 11, 2023
Lung Immune Therapy Evaluation (LITE) Risk, a Novel Prognostic Model for Patients With Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint BlockadeVishal Navani, Daniel E Meyers, Yibing Ruan, et al.
Nucleic Acids Research|October 3, 2020
A high-throughput alpha particle irradiation system for monitoring DNA damage repair, genome instability and screening in human cell and yeast model systemsFintan K T Stanley, N Daniel Berger, Dustin D Pearson, et al.
Cancer Causes & Control : CCC|March 18, 2022
Lifestyle factors and lung cancer risk among never smokers in the Canadian Partnership for Tomorrow's Health (CanPath)Rachel A Murphy, Maryam Darvishian, Jia Qi, et al.
CMAJ Open|October 13, 2016
Design, methods and demographics from phase I of Alberta's Tomorrow Project cohort: a prospective cohort profilePaula J Robson, Nathan M Solbak, Tiffany R Haig, et al.
Current Oncology (Toronto, Ont.)|October 27, 2022
Prevalence, Treatment Patterns, and Outcomes of Individuals with <i>EGFR</i> Positive Metastatic Non-Small Cell Lung Cancer in a Canadian Real-World Setting: A Comparison of Exon 19 Deletion, L858R, and Exon 20 Insertion <i>EGFR</i> Mutation CarriersDylan E O'Sullivan, Tamer N Jarada, Amman Yusuf, et al.
Cancer Causes & Control : CCC|April 18, 2022
Correction to: Lifestyle factors and lung cancer risk among never smokers in the Canadian Partnership for Tomorrow's Health (CanPath)Rachel A Murphy, Maryam Darvishian, Jia Qi, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|May 26, 2021
Estimating the future cancer management costs attributable to modifiable risk factors in CanadaYibing Ruan, Abbey E Poirier, Joy Pader, et al.
Canadian Liver Journal|December 25, 2023
Real-world treatment patterns, clinical outcomes, and health care resource utilization in advanced unresectable hepatocellular carcinomaDylan E O'Sullivan, Devon J Boyne, Iqra A Syed, et al.
Surgical Endoscopy|November 4, 2020
Morphology of the major papilla predicts ERCP procedural outcomes and adverse eventsRachid Mohamed, B Cord Lethebe, Emmanuel Gonzalez-Moreno, et al.
Journal of Bacteriology|September 13, 2021
Fluorescence Imaging-Based Discovery of Membrane Domain-Associated Proteins in <i>Mycobacterium smegmatis</i>Corelle A Z Rokicki, James R Brenner, Alexander H Dills, et al.
Pageof 99

Showing results (671-680 of 989) with videos related to

Sort By:
Pageof 99
Clinical Lung Cancer|February 11, 2023
Lung Immune Therapy Evaluation (LITE) Risk, a Novel Prognostic Model for Patients With Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint BlockadeVishal Navani, Daniel E Meyers, Yibing Ruan, et al.
Nucleic Acids Research|October 3, 2020
A high-throughput alpha particle irradiation system for monitoring DNA damage repair, genome instability and screening in human cell and yeast model systemsFintan K T Stanley, N Daniel Berger, Dustin D Pearson, et al.
Cancer Causes & Control : CCC|March 18, 2022
Lifestyle factors and lung cancer risk among never smokers in the Canadian Partnership for Tomorrow's Health (CanPath)Rachel A Murphy, Maryam Darvishian, Jia Qi, et al.
CMAJ Open|October 13, 2016
Design, methods and demographics from phase I of Alberta's Tomorrow Project cohort: a prospective cohort profilePaula J Robson, Nathan M Solbak, Tiffany R Haig, et al.
Current Oncology (Toronto, Ont.)|October 27, 2022
Prevalence, Treatment Patterns, and Outcomes of Individuals with <i>EGFR</i> Positive Metastatic Non-Small Cell Lung Cancer in a Canadian Real-World Setting: A Comparison of Exon 19 Deletion, L858R, and Exon 20 Insertion <i>EGFR</i> Mutation CarriersDylan E O'Sullivan, Tamer N Jarada, Amman Yusuf, et al.
Cancer Causes & Control : CCC|April 18, 2022
Correction to: Lifestyle factors and lung cancer risk among never smokers in the Canadian Partnership for Tomorrow's Health (CanPath)Rachel A Murphy, Maryam Darvishian, Jia Qi, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|May 26, 2021
Estimating the future cancer management costs attributable to modifiable risk factors in CanadaYibing Ruan, Abbey E Poirier, Joy Pader, et al.
Canadian Liver Journal|December 25, 2023
Real-world treatment patterns, clinical outcomes, and health care resource utilization in advanced unresectable hepatocellular carcinomaDylan E O'Sullivan, Devon J Boyne, Iqra A Syed, et al.
Surgical Endoscopy|November 4, 2020
Morphology of the major papilla predicts ERCP procedural outcomes and adverse eventsRachid Mohamed, B Cord Lethebe, Emmanuel Gonzalez-Moreno, et al.
Journal of Bacteriology|September 13, 2021
Fluorescence Imaging-Based Discovery of Membrane Domain-Associated Proteins in <i>Mycobacterium smegmatis</i>Corelle A Z Rokicki, James R Brenner, Alexander H Dills, et al.
Pageof 99